Evidence map›Paper›PMID 34522760›Full record

ArticleOne health (Amsterdam, Netherlands)2021

Duration of carriage of multidrug-resistant bacteria in dogs and cats in veterinary care and co-carriage with their owners.

Valentina Dazio, Aurélien Nigg, Janne S Schmidt, Michael Brilhante, Edgar I Campos-Madueno, Nico Mauri, Stefan P Kuster, Stefanie Gobeli Brawand, Barbara Willi, Andrea Endimiani and 2 more

Open access · goldAbstract read
In one paragraph

Article in One health (Amsterdam, Netherlands), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Carbapenemase-Producing Enterobacterales in Pets: A New Threat From Veterinary Clinics.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  3. Article
  4. Microorganisms · 2026
    Review
  5. Review
  6. Article
  7. The transmission risk of multidrug-resistant organisms between hospital patients and their pets - a case-control study, Germany, 2019 to 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The Diversity and Zoonotic Potential ofAntibiotics (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Extended-Spectrum Beta-Lactamase-Producing and Carbapenem-ResistantInternational journal of environmental research and public health · 2021
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Valentina DazioDepartment of Clinical Veterinary Medicine, University of Bern, Switzerland.
Aurélien NiggInstitute of Veterinary Bacteriology, University of Bern, Switzerland.
Janne S SchmidtClinic for Small Animal Internal Medicine, University of Zurich, Switzerland.
Michael BrilhanteInstitute of Veterinary Bacteriology, University of Bern, Switzerland.
Edgar I Campos-MaduenoInstitute for Infectious Diseases, Faculty of Medicine, University of Bern, Switzerland.
Nico MauriTierklinik Aarau West AG, Oberentfelden, Switzerland.
Stefan P KusterDivision of Infectious Diseases and Hospital Epidemiology, University and University Hospital of Zurich, Faculty of Medicine, Zurich, Switzerland.
Stefanie Gobeli BrawandInstitute of Veterinary Bacteriology, University of Bern, Switzerland.
Barbara WilliClinic for Small Animal Internal Medicine, University of Zurich, Switzerland.
Andrea EndimianiInstitute for Infectious Diseases, Faculty of Medicine, University of Bern, Switzerland.
Vincent PerretenInstitute of Veterinary Bacteriology, University of Bern, Switzerland.
Simone SchullerDepartment of Clinical Veterinary Medicine, University of Bern, Switzerland.
University of Bern · CHUniversity of Zurich · CHHirslanden Klinik Aarau · CHUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe emergence and spread of multidrug-resistant organisms (MDROs) represent a threat to human and animal health.

objectivesTo assess duration of carriage of MDROs in dogs and cats presented to veterinary clinics/hospitals in Switzerland. To estimate prevalence, duration of and risk factors for MDRO carriage in their owners and the occurrence of co-carriage in owner-pet pairs.

methodsProspective, longitudinal, observational study. Nasal swabs and fecal samples were collected from 50 owners of dogs and cats presented to 3 large veterinary hospitals, 1 medium-sized clinic and 1 practice. If pet or owner tested positive for a MDRO, follow-up samples were collected for up to 8 months. Methicillin-resistant (MR)

resultsFive out of 50 owners carried 3rd generation cephalosporin-resistant Enterobacterales (3GC-R-Ent.), and 5/50 MRCoNS. In 3 dogs and 4 cats carriage of 3GC-R-Ent. persisted for up to 136 days after discharge (median 99 days, IQR 83 days, range 36-136 days), in two cats isolates were carbapenem-resistant. Owner-pet co-carriage was not observed. No specific risk factors for MDRO carriage in owners were identified.

conclusionsAfter discharge from veterinary care, dogs and cats may carry 3GC-R-Ent. for prolonged time periods. Carriage of MDROs was common in owners, but pet-owner co-carriage of the same MDRO was not observed.

Indexed as

3GC-R-Ent., Third Generation Cephalosporin-resistant Enterobacterales3GC-R, Third Generation Cephalosporin-resistantAMR, Antimicrobial resistanceCarbapenemase-producing EnterobacteralesCI, Confidence intervalCLSI, Clinical and Laboratory Standards InstituteCo-carriageCOL-R, Colistin-resistantCompanion animalCP, Carbapenemase-producingCR, Carbapenem-resistantCRE, Carbapenem-resistant EnterobacteralesERIC-PCR, Enterobacterial repetitive intergenic consensus polymerase chain reactionESBL-E. coli, ESBL-producing Escherichia coliESBL, Extended spectrum β-lactamaseESBL-KP, ESBL-producing Klebsiella pneumoniaeEUCAST, European Committee on Antimicrobial Susceptibility TestingExtended-spectrum β-lactamaseIQR, Interquartile rangeKP, Klebsiella pneumoniaeMALDI-TOF MS, Matrix-assisted laser desorption/ionization time of flight mass spectrometryMDR, Multidrug-resistantMDROs, Multidrug-resistant organismsMICs, Minimal inhibitory concentrationsMLST, Multilocus sequence typingMRCoNS, Methicillin-resistant coagulase-negative staphylococciMR, Methicillin-resistantMRSA, Methicillin-resistant Staphylococcus aureusMRSP, Methicillin-resistant Staphylococcus pseudintermediuspAmpC, Plasmid-encoded AmpCREP-PCR, Repetitive element palindromic polymerase chain reactionST, Sequence typeTMP-S, Trimethoprim/sulfamethoxazoleTransmissionWGS, Whole-genome sequencing

Identifiers

PMID34522760
PMCPMC8424212
OpenAlexW3196350597

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.